EVOKE PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.45 USD | +2.27% |
|
+1.47% | -57.16% |
| 24/04 | Transcript : Evoke Pharma, Inc. - Special Call | |
| 21/03 | Evoke Pharma, Inc. Announces Board Changes as of March 31, 2024 | CI |
Chart calendar Evoke Pharma, Inc.
6280487574d96159e0baeeb47.mEuRedqNv44q8DDJjyGlL8e6xsCrq3yYV6cNQ44zJ7k.qgzoTano1eNZtQfk_H7HeKONsLT5-CreBtNBCsRKVvDaAsYri-Ha4l6GdQ~51eea2d3ac72602df4d079955f7b1e69
Upcoming events on Evoke Pharma, Inc.
Past events on Evoke Pharma, Inc.
| 24/04/2024 09:30 pm | Investor Meeting - Key Opinion Leader |
| 15/03/2024 02:00 am | Q4 2023 Earnings Call |
| 15/03/2024 01:35 am | Q4 2023 Earnings Release |
| 09/11/2023 07:00 pm | Q3 2023 Earnings Release |
| 25/10/2023 09:20 pm | American College of Gastroenterology Meeting - Presentation Number: 67 |
| 12/08/2023 11:00 pm | American Neurogastroenterology and Motility Society Meeting - Poster Number: 126 |
| 10/08/2023 06:00 pm | Q2 2023 Earnings Release |
| 22/06/2023 08:30 pm | Investor Meeting - Key Opinion Leader |
| 16/05/2023 01:35 am | Q1 2023 Earnings Release |
| 10/05/2023 09:00 pm | Annual General Meeting |
| 09/05/2023 06:30 pm | Digestive Disease Week Conference |
| 07/05/2023 11:00 pm | Digestive Disease Week - Poster Number: Su1651 |
| 23/03/2023 10:00 pm | Academy of Managed Care Pharmacy Meeting - Poster No: K2 |
| 22/03/2023 02:00 am | Q4 2022 Earnings Call |
| 22/03/2023 01:35 am | Q4 2022 Earnings Release |
| 10/11/2022 03:00 am | Q3 2022 Earnings Call |
| 10/11/2022 02:35 am | Q3 2022 Earnings Release |
| 21/10/2022 | American College of Gastroenterology Scientific Meeting |
| 12/09/2022 06:00 pm | H.C. Wainwright Global Investment Conference |
| 11/08/2022 02:00 am | Interim 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,02 0,85 -97.28% | 1,62 1,77 -8.32% | 2,51 2,60 -3.55% | 5,18 5,14 0.85% | 14,1 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,15 -7,43 3.71% | -13,0 -13,7 4.85% | -8,15 -9,34 12.68% | -7,79 -8,03 3.09% | -7,43 -7,36 -0.98% | -3,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,13 -7,41 3.77% | -13,2 -13,8 4.93% | -8,54 -9,63 11.29% | -8,22 -8,50 3.23% | -7,79 -7,71 -1.11% | -3,36 |
|
Net income Million USD | Released Forecast Spread | -7,13 -7,24 1.51% | -13,2 -13,8 4.93% | -8,54 -9,63 11.29% | -8,22 -8,50 3.23% | -7,79 -7,71 -1.11% | -3,36 |
|
EPS USD | Released Forecast Spread | -3,84 -3,72 -3.23% | -6,24 -6,42 2.8% | -3,24 -3,60 10% | -2,62 -2,58 -1.55% | -2,33 -2,23 -4.48% | -0,23 |
| Announcement Date | 12/03/20 | 11/03/21 | 08/03/22 | 21/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,36 0,51 -28.88% | 0,42 0,54 -21.8% | 0,46 0,58 -20.38% | 0,83 0,57 45.47% | 0,80 0,89 -10.42% | 0,81 1,00 -19.2% | 1,13 1,10 3.23% | 1,56 1,26 23.74% | 1,68 1,63 2.7% | 2,14 | 2,98 | 4,10 | 4,86 |
|
EBIT Million USD | Released Forecast Spread | -1,55 -2,73 43.34% | -2,05 -1,37 -50.05% | -2,11 -2,06 -2.46% | -1,91 -2,15 11.04% | -1,71 -1,96 12.63% | -2,16 -2,01 -7.49% | -1,78 -2,52 29.08% | -1,60 -2,01 20.15% | -1,89 -1,82 -3.96% | -1,70 | -1,13 | -0,38 | 0,20 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,67 -2,76 39.41% | -2,17 -1,49 -45.88% | -2,23 -2,19 -2.21% | -2,01 -2,27 11.44% | -1,80 -2,08 13.22% | -2,24 -2,12 -5.86% | -1,87 -2,63 29.03% | -1,69 -2,09 19.03% | -1,99 -1,90 -4.49% | -1,78 | -1,22 | -0,47 | 0,11 |
|
Net income Million USD | Released Forecast Spread | -1,67 -2,76 39.41% | -2,17 -1,49 -45.88% | -2,23 -2,19 -2.21% | -2,01 -2,27 11.44% | -1,80 -2,08 13.22% | -2,24 -2,12 -5.86% | -1,87 -2,63 29.03% | -1,69 -2,09 19.03% | -1,99 -1,90 -4.49% | -1,78 | -1,22 | -0,47 | 0,11 |
|
EPS USD | Released Forecast Spread | -0,72 -0,96 25% | -0,84 -0,48 -75% | -0,71 -0,60 -18.33% | -0,60 -0,66 9.09% | -0,53 -0,53 0% | -0,67 -0,58 -15.52% | -0,56 -0,73 23.29% | -0,51 -0,62 17.74% | -0,59 -0,50 -18% | -0,21 | -0,14 | -0,02 | 0,01 |
| Announcement Date | 08/03/22 | 10/05/22 | 10/08/22 | 09/11/22 | 21/03/23 | 15/05/23 | 10/08/23 | 09/11/23 | 14/03/24 | - | - | - | - |
| Today 01:35 am | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| Today 01:35 am | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 02/05/2024 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 02/05/2024 | AMGEN INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:00 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 02/05/2024 05:00 pm | ORGANON & CO.: Q1 2024 Earnings Release |
| 03/05/2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 03/05/2024 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 03/05/2024 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 03/05/2024 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
Past sector events for Evoke Pharma, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EVOK Stock
- Calendar Evoke Pharma, Inc.
